Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Deborah Cosentini"'
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report
Autor:
Elena Fassi, Vito Amoroso, Deborah Cosentini, Vittorio Ferrari, Marta Laganà, Alfredo Berruti, Pierluigi di Mauro
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionRegorafenib is an oral multi-targeted tyrosine kinase inhibitor (TKI) indicated for the treatment of various tumor types, including metastatic gastrointestinal stromal tumors (GIST), as a third-line systemic therapy. Erythrocytosis, which
Externí odkaz:
https://doaj.org/article/270a21599063485e850714719948f0e0
Autor:
Rebecca Pedersini, Pierluigi di Mauro, Vito Amoroso, Vincenza Castronovo, Manuel Zamparini, Sara Monteverdi, Lara Laini, Greta Schivardi, Deborah Cosentini, Salvatore Grisanti, Sara Marelli, Luigi Ferini Strambi, Alfredo Berruti
Publikováno v:
Breast, Vol 66, Iss , Pp 162-168 (2022)
Introduction: Whether adjuvant therapy with aromatase inhibitors (AIs) causes sleep disturbances or not in postmenopausal women with early breast cancer (EBC) is still a controversial issue. Methods: Between March 2014 and November 2017, validated qu
Externí odkaz:
https://doaj.org/article/99cd9dfa477048b8bb7ce1056066d7d3
Autor:
Rebecca Pedersini, Deborah Cosentini, Luca Rinaudo, Manuel Zamparini, Fabio Massimo Ulivieri, Pierluigi di Mauro, Filippo Maffezzoni, Sara Monteverdi, Walter Vena, Lara Laini, Vito Amoroso, Edda Lucia Simoncini, Davide Farina, Gherardo Mazziotti, Alfredo Berruti
Publikováno v:
Bone Reports, Vol 18, Iss , Pp 101654- (2023)
Background: Bone mineral density (BMD) lacks sensitivity in individual fracture risk assessment in early breast cancer (EBC) patients treated with aromatase inhibitors (AIs). New dual-energy X-ray absorptiometry (DXA) based risk factors are needed. M
Externí odkaz:
https://doaj.org/article/ba248560d4cc46be9270b812a4d5b509
Autor:
Andrea Delbarba, Deborah Cosentini, Paolo Facondo, Marta Laganà, Letizia Chiara Pezzaioli, Valentina Cremaschi, Andrea Alberti, Salvatore Grisanti, Carlo Cappelli, Alberto Ferlin, Alfredo Berruti
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
ObjectiveHypogonadism is common in male patients with adrenocortical carcinoma (ACC) who are under treatment with mitotane, but the phenomenon is underestimated, and its prevalence has been poorly studied. This single-center retrospective longitudina
Externí odkaz:
https://doaj.org/article/d02652cc18794a5ba94c0a811474aae3
Autor:
Luca Licata, Deborah Cosentini, Rita De Sanctis, Monica Iorfida, Elena Rota Caremoli, Andrea Vingiani, Edda Lucia Simoncini, Giancarlo Pruneri, Elisabetta Munzone, Giampaolo Bianchini, Alberto Zambelli, Carlo Tondini
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The increasing understanding of breast cancer biology has provided the basis for the development of multigene signatures aimed to improve the capability of clinicians to assess patients’ prognostication and risk stratification. Incorporating these
Externí odkaz:
https://doaj.org/article/6a67d1afaa084dd89c84e592f33d434c
Autor:
Pierluigi di Mauro, Greta Schivardi, Rebecca Pedersini, Lara Laini, Andrea Esposito, Vito Amoroso, Marta Laganà, Salvatore Grisanti, Deborah Cosentini, Alfredo Berruti
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundTriple-negative breast cancer (TNBC) is an aggressive cancer subtype, owing to its high metastatic potential: Patients who develop brain metastases (BMs) have a poor prognosis due to the lack of effective systemic treatments. Surgery and ra
Externí odkaz:
https://doaj.org/article/3cf7983c09e8463db74984731e41047e
Autor:
Sandra Sigala, Christina Bothou, David Penton, Andrea Abate, Mirko Peitzsch, Deborah Cosentini, Guido A. M. Tiberio, Stefan R. Bornstein, Alfredo Berruti, Constanze Hantel
Publikováno v:
Cells, Vol 12, Iss 18, p 2274 (2023)
The authors made the following changes to their paper [...]
Externí odkaz:
https://doaj.org/article/d15a5a41225746c0b2555cc5752f7cb5
Autor:
Rebecca Pedersini, Pierluigi di Mauro, Sara Bosio, Barbara Zanini, Alessandra Zanini, Vito Amoroso, Antonella Turla, Lucia Vassalli, Mara Ardine, Sara Monteverdi, Manuel Zamparini, Cristina Gurizzan, Deborah Cosentini, Chiara Ricci, Edda Lucia Simoncini, Alfredo Berruti
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Change in eating habits in early breast cancer (EBC) patients during chemotherapy has been poorly studied in the literature. The primary aim of this study was to prospectively evaluate food preferences and weight change in EBC patients befor
Externí odkaz:
https://doaj.org/article/a5d7e99d50ab4bd186cb0d9642d9efe7
Autor:
Mariangela Tamburello, Andrea Abate, Elisa Rossini, Ram Manohar Basnet, Daniela Zizioli, Deborah Cosentini, Constanze Hantel, Marta Laganà, Guido Alberto Massimo Tiberio, Salvatore Grisanti, Maurizio Memo, Alfredo Berruti, Sandra Sigala
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 7, p 6829 (2023)
Background: Adrenocortical cancer (ACC) is a rare malignancy with a dismal prognosis. The treatment includes mitotane and EDP chemotherapy (etoposide, doxorubicin, and cisplatin). However, new therapeutic approaches for advanced ACC are needed, parti
Externí odkaz:
https://doaj.org/article/ca50272ad95a4ac68371cac657d07666
Autor:
Antonella Turla, Manuel Zamparini, Massimo Milione, Salvatore Grisanti, Vito Amoroso, Rebecca Pedersini, Deborah Cosentini, Alfredo Berruti
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundOvarian strumal carcinoid is a rare tumor in which thyroid (struma) and carcinoid components coexist. The disease is generally considered to be a borderline malignancy, however, cases with metastatic disease have been described. No data in
Externí odkaz:
https://doaj.org/article/ecff172b1cad4fcd9e979a571c20cf63